SNCA and Parkinson disease: The presence of α-synuclein-immunoreactive pathology, which places MSA amongst the broad category of synucleinopathies including Parkinson's disease and dementia with Lewy bodies, suggests that an abnormality of α-synuclein may play a role in the mechanisms of cell death in MSA.